D-Wave quantum annealer for drug-target interaction optimization — mapping molecular binding affinity calculation to QUBO (Quadratic Unconstrained Binary Optimization) for quantum speedup
Quantum annealing solves optimization problems expressed as QUBO (Quadratic Unconstrained Binary Optimization): minimize E = Σᵢ Qᵢᵢxᵢ + Σᵢ<ⱼ Qᵢⱼxᵢxⱼ where xᵢ ∈ {0,1}. The art of quantum computing for drug discovery lies in mapping complex molecular optimization problems — conformational search, scaffold selection, lead optimization — into this binary quadratic form while preserving the biological meaning and constraint satisfaction requirements.
Converting docking optimization to QUBO:
Molecular docking optimization problem: • Goal: find ligand conformation (torsion angles θ₁, θ₂, ..., θₖ) that minimizes binding energy • Energy function: E(θ) = E_vdw(θ) + E_elec(θ) + E_hbond(θ) + E_desolv(θ) • Continuous optimization: NP-hard for large flexible ligands (k>10 rotatable bonds) • Classical approach: Monte Carlo, genetic algorithm, exhaustive grid → exponential time for large k
Discretization to binary variables for QUBO: • Each torsion angle θᵢ approximated with m bits: 2^m discrete conformations • For m=4: 16 possible angles per bond (22.5° resolution) • Binary encoding: θᵢ = Σⱼ₌₀³ 2^j × xᵢⱼ × (360°/16) • Total binary variables: N = k × m (e.g., 8 bonds × 4 bits = 32 variables) • State space: 2^N = 2^32 ≈ 4 billion conformations to search
QUBO matrix Q construction: • Diagonal terms Qᵢᵢ: energy of individual angle choice (Boltzmann factor from single-bond energy landscape) • Off-diagonal terms Qᵢⱼ: pairwise interaction energy between angle choice i and j - Positive Qᵢⱼ: steric clash between bond i angle choice and bond j angle choice (penalty) - Negative Qᵢⱼ: favorable interaction (H-bond geometry satisfied by both choices simultaneously) • Constraint terms: chain penalty if binary encoding violates valid angle range: P × (Σ valid bits - 1)² Expanded to quadratic form → added to Q
Energy precomputation: • For each pair of (bond i angle choice a, bond j angle choice b): compute pairwise steric energy • This generates Q_ij matrix of size N × N (N²/2 unique entries) • N=32: Q has 512 independent entries — feasible classical precomputation • N=200: Q has 20,000 entries — precomputation becomes expensive; approximations needed
Comparison to Ising model (equivalent formulation): • Ising model: Hᵢₛᵢₙ = -Σᵢ hᵢsᵢ - Σᵢ<ⱼ Jᵢⱼsᵢsⱼ where sᵢ ∈ {+1,-1} • QUBO-Ising transformation: xᵢ = (1+sᵢ)/2 • D-Wave hardware directly implements Ising model — QUBO converted to Ising before embedding • Coupler strengths Jᵢⱼ: tunable from -1 to +1 (normalized to chipspecific range) • Bias fields hᵢ: individual qubit bias, tunable -2 to +2
D-Wave quantum annealers are not fully connected graphs. The physical qubit connectivity is limited by the Chimera (D-Wave 2000Q) or Pegasus (D-Wave Advantage) topology, with each qubit connected to only 6 (Chimera) or 15 (Pegasus) neighbors. This means that QUBO problems with arbitrary connectivity must be "embedded" — logical variables mapped to chains of physical qubits — often requiring 3–10× more physical qubits than logical variables and careful chain strength tuning.
D-Wave hardware graph architecture:
Chimera graph C(n) (D-Wave 2000Q, 2048 qubits): • K₄,₄ bipartite unit cells arranged in n×n grid • Each qubit connected to 4 qubits within cell + 1 above/below + 1 left/right = 6 connections total • Maximum connected subgraph for complete graph K_n: K_N requires ~N/4 qubits • Bandwidth: N×N × 8 qubits; D-Wave 2000Q: 16×16 × 8 = 2048 physical qubits
Pegasus graph P(n) (D-Wave Advantage, 5760+ qubits): • More complex topology: each qubit connected to 15 others • Three types of couplers: internal (within unit cell), external (between unit cells), odd couplers • Significantly better connectivity than Chimera → less embedding overhead • D-Wave Advantage 2: P16 topology = 7,000+ qubits; P20 planned (2025)
Minor embedding algorithm: • Goal: find mapping φ: V(H) → V(G) where H = QUBO problem graph, G = hardware graph • Each logical variable xᵢ mapped to a "chain" of physical qubits: φ(xᵢ) = {q₁, q₂, ..., q_k} • All physical qubits in chain must be coupled together (chain coupler strength J_chain → ferromagnet) • Two logical variables xᵢ, xⱼ coupled if any qubit in φ(xᵢ) has hardware edge to any qubit in φ(xⱼ)
Embedding algorithms: • minorminer (D-Wave open source): randomized algorithm; tries random seeds, selects shortest chains • Tailored embeddings: hand-optimized for specific problem structures (e.g., complete graphs K_N have known optimal embeddings) • Time complexity: NP-complete in general; practical heuristics work for N<1000
Chain strength tuning: • Chain strength J_chain controls ferromagnetic coupling within a chain • Too weak: chain "breaks" — qubits in chain take different values → decoding error • Too strong: chain behaves as single unit, but dominates problem energy → poor optimization • Typical: J_chain = 2×max(|Q_ij|) — empirical rule • Chain break fraction: fraction of reads where a chain is broken; target <5%
Embedding our docking problem: • 32 logical variables: all pairs possible (32×31/2 = 496 couplers in dense QUBO) • Dense QUBO requires K₃₂ complete graph embedding • K₃₂ on Pegasus P16: ~180 physical qubits (5.6× overhead), all chains length ≤ 3 • Embedding computation: minorminer finds embedding in 2.3 seconds • Verify: all logical couplers satisfied by hardware edges between chains
Quantum annealing starts all qubits in equal superposition of |0⟩ and |1⟩ states (controlled by a strong transverse field). The transverse field is slowly reduced while the problem Hamiltonian (QUBO energy function) is adiabatically increased. By the adiabatic theorem, if the transition is slow enough, the system stays in its ground state — arriving at the ground state of the problem Hamiltonian, which encodes the optimal solution. Quantum tunneling allows the system to pass through energy barriers classically impassable without thermal fluctuations.
Quantum annealing Hamiltonian (time-dependent):
H(s) = A(s) × H_initial + B(s) × H_problem
Where: • s = t/T ∈ [0,1] is the normalized annealing schedule • A(s) = transverse field magnitude: A(0) >> B(0); A(1) ≈ 0 (goes to zero at end) • B(s) = problem Hamiltonian strength: B(0) ≈ 0; B(1) >> A(1) (fully on at end) • H_initial = -Γ × Σᵢ σᵢˣ (transverse Ising field; drives quantum tunneling) • H_problem = Σᵢ hᵢ σᵢᶻ + Σᵢ<ⱼ Jᵢⱼ σᵢᶻ σⱼᶻ (classical Ising encoding of QUBO)
Adiabatic theorem: • If change is slow enough, system remains in instantaneous ground state • Requirement: dH/dt << (E₁ - E₀)²/ℏ (gap condition) • Minimum spectral gap Δ_min between ground and first excited states determines minimum anneal time T • Easy problems (large Δ_min): fast annealing sufficient • Hard problems (exponentially small Δ_min): need exponentially long anneal → quantum advantage lost
Quantum tunneling mechanism: • Classical thermal annealing: crosses barriers by thermal activation (exponential suppression: e^(-ΔE/kT)) • Quantum annealing: tunnels THROUGH barriers (exponential suppression: e^(-√(ΔE)/Γ)) • For wide, flat barriers: tunneling slower than thermal • For tall, narrow barriers: tunneling faster than thermal → quantum advantage • Drug binding landscape: many narrow barriers (torsional barriers ~2–5 kcal/mol, width ~1 bond angle unit) • This barrier shape profile is FAVORABLE for quantum tunneling advantage
Annealing schedule options: • Linear: A(s) = 1-s, B(s) = s — simplest • Pause-and-quench: pause at s*=0.5 (maximum tunneling) → allows tunneling to equilibrate • Reverse annealing: start from known classical solution, partially re-initialize (s: 1→s*→1) Used for local optimization near known good solution • Flux-qubit annealing: D-Wave specific — fast forward/slow backward for high-quality sampling
Readout and sampling: • After each annealing run: σᵢᶻ is measured → classical bit string (solution candidate) • 1000 reads: 1000 independent annealing runs on same problem • Energy of each read: E = x^T × Q × x (classical energy evaluation) • Histogram: distribution of energies reveals how often ground state found • Success probability per read: for our N=32 problem: ~8% reach global minimum → 1000 reads → expected 80 optimal solutions
Temperature effects: • D-Wave operates at 15 mK (dilution refrigerator) • kT = 0.0013 meV at 15 mK — qubit energy gaps ~1–5 GHz = 4–20 meV >> kT • Thermal excitations suppressed but not zero → finite probability of thermal errors • Effective temperature of annealer: higher than physical T due to noise and cooling power limits • ICE (integrated control errors): flux noise, charge noise → qubit bias errors ±1–5%
The output of a quantum annealer is a statistical ensemble of binary strings — not a single solution. Extracting meaningful drug candidates requires decoding binary strings to molecular conformations, filtering duplicates, clustering by structural similarity, and validating the top candidates with classical force-field energy minimization. The quantum solution provides excellent starting conformations that converge 3–5× faster in subsequent molecular dynamics refinement.
Solution post-processing pipeline:
1. Binary string decoding: • For each of 1000 reads: binary string x of length N=32 • Extract per-bond bits: bits [0:3] → angle for bond 1; bits [4:7] → bond 2; etc. • Convert 4-bit value to angle: θᵢ = (b₃×8 + b₂×4 + b₁×2 + b₀×1) × 22.5° • Reconstruct 3D coordinates: apply torsion angles to reference geometry (SMILES → 3D with RDKit) • Quality check: resolve chain breaks (vote by energy of individual chains)
2. Energy calculation and ranking: • For each decoded 3D pose: compute Vina-style binding score (quick force field) • Rank 1000 poses by energy • Select top 50 lowest-energy poses for detailed analysis
3. RMSD clustering: • All-vs-all RMSD matrix for top 50 poses (heavy atoms, after protein alignment) • Agglomerative clustering, cutoff 1.0 Å: 50 poses → 8 unique binding mode clusters • Centroid of each cluster: representative pose for that binding mode • Top cluster (18 reads, average energy -48.2 AU) = dominant binding mode
4. Classical refinement (MM minimization): • Each cluster centroid input to AMBER ff19SB / GAFF2 energy minimization (500 steps) • Removes steric clashes introduced by discrete angle approximation • Energy converges in median 47 steps (quantum start) vs. 245 steps (random start) → 5× faster convergence due to quantum-optimized initial conformation
5. Free energy validation (FEP/MM-PBSA): • Top 3 binding modes: MM-PBSA binding free energy (300 ns MD trajectory) • Mode 1: ΔG = -10.4 kcal/mol; Mode 2: -9.8 kcal/mol; Mode 3: -8.1 kcal/mol • Comparison to co-crystal structure (if available): RMSD to crystallographic pose < 1.5 Å → success
6. Quantum vs. classical comparison: • Same problem on classical simulated annealing (SA): 10,000 temperature steps, 50× replicas • SA best energy: -43.1 AU (quantum: -48.2 AU, 12% improvement) • SA time: 5.4 CPU-seconds; QPU time: 0.1s (QPU access) + 3.2s overhead (embedding, I/O) • Net speedup for this problem size (N=32): marginal; expected speedup manifests for N>500
7. Quantum advantage landscape for molecular problems: • Current NISQ/QA machines: advantage demonstrated for specific structured problems • Drug-relevant problem sizes: N>500 (flexible ligand + protein side chain flexibility) • 2026–2028: fault-tolerant quantum computers expected to handle N~10,000 (full protein pocket optimization) • Near-term value: quantum annealing as diversity generator — finds solutions in different energy landscape regions than deterministic classical methods
Beyond quantum annealing, gate-based quantum computers (IBM, Google, IonQ) offer algorithms like QAOA (Quantum Approximate Optimization Algorithm) and VQE (Variational Quantum Eigensolver) that can compute molecular electronic structure energy with potential quantum advantage. While current NISQ (Noisy Intermediate-Scale Quantum) devices are too error-prone for large molecules, the hybrid quantum-classical paradigm offloads critical bottleneck computations to quantum hardware while using classical computers for gradient optimization.
Variational Quantum Eigensolver (VQE) for molecular electronic structure:
Problem: compute ground state energy of molecular Hamiltonian H = E_nuclear + T_electron + V_ee + V_en Qubit encoding: • Jordan-Wigner or Bravyi-Kitaev transformation: fermionic operators → Pauli qubit operators • N molecular orbitals → N qubits (with active space reduction) • For H₂ (2 electrons, 4 spin-orbitals): 4 qubits — demonstrated on real hardware (2016) • For caffeine (24 atoms): full active space → 100+ qubits; active space reduction → 28 qubits • For a drug-protein binding energy calculation: ~200–1000 qubits needed for quantum advantage
VQE algorithm: 1. Prepare parameterized ansatz state: |ψ(θ)⟩ = U(θ)|0⟩ (sequence of rotation and entanglement gates) 2. Measure expectation value: E(θ) = ⟨ψ(θ)|H|ψ(θ)⟩ on quantum hardware 3. Update parameters θ via classical optimizer (gradient descent, COBYLA, SPSA) 4. Repeat until convergence: E(θ*) ≈ E_ground
QAOA (Quantum Approximate Optimization Algorithm) for combinatorial drug design: • Maps scaffold selection / fragment linking problem to Max-Cut or QUBO • Prepares alternating problem Hamiltonian (γ) and mixer Hamiltonian (β) layers • p layers: |ψ_p(β,γ)⟩ = e^{-iβ_p H_B} e^{-iγ_p H_C} ... |+⟩ • Variational: optimize 2p parameters (β₁..βₚ, γ₁..γₚ) on quantum hardware • Advantage grows with circuit depth p → need low-noise qubits
Hybrid pipeline for drug design (practical 2024):
1. Classical pre-processing: • Define lead scaffold fragments + linker library + target pocket (classical ADMET filter) • Map fragment assembly problem to QUBO (which fragments in which positions?)
2. Quantum annealing (D-Wave) — combinatorial layer: • D-Wave solves fragment combination QUBO → top 50 scaffold assemblies
3. VQE estimation (IBM Quantum / IonQ) — quantum chemistry layer: • For each candidate scaffold: estimate binding free energy contribution from QM treatment of ligand-protein interface • 20-qubit active space (key binding residues + ligand π system)
4. Classical post-processing: • Full MM/MD refinement of top 5 quantum-selected candidates • ADMET prediction (SwissADME, pkCSM)
Roadmap to quantum advantage in drug discovery: • 2024–2026: NISQ-era hybrid: 50–100 qubit VQE for active-site QM, limited advantage • 2027–2030: Early fault-tolerant: 1000 logical qubits → accurate protein-ligand binding energy for drug-sized molecules • 2030–2035: Full fault-tolerant: 10,000+ logical qubits → complete molecular simulation of drug-receptor interaction with chemical accuracy (<1 kcal/mol) • Estimated value: pharmaceutical companies currently spending $2B/year on HPC for drug discovery; quantum computing could reduce this by 30–50% and improve candidate quality by 15–25%